Uncategorized
Touchstone Launches TLCI ETF To Capitalize On Global Growth
TLCI, Touchstone’s actively managed ETF, targets non-U.S. large-cap equities for long-term growth. It’s the third ETF launch this year, bringing the total to 10. read more
Trump Vs. Musk: Tesla To Be Hurt By Tariffs On Mexico Despite Friendship
Ford, GM and Stellantis could be hit hard by tariffs on Canada and Mexico. Tesla isn’t immune from higher costs and could pay more for parts from Mexico. read more
Geopolitics, Tariffs, Supply Glut: What’s Next For Oil ETFs?
Energy sector faces investor scrutiny due to recent developments. ETFs like XLE, VDE, and UNG offer exposure to energy companies amid market uncertainty. read more
Alzheimer’s Drugs From Eli Lilly And Biogen Still Deemed Too Costly For NHS Funding
NICE has upheld its decision not to recommend Alzheimer’s treatments donanemab and lecanemab for NHS use, citing high costs and limited benefit. Stakeholders can submit feedback until March 27, 2025, before final recommendations are issued. read more
Dogecoin Whales Accumulating 150 Million DOGE Despite Price Drop: What Do They Know?
Despite Dogecoin’s (CRYPTO: DOGE) lackluster performance, whale investors are aggressively accumulating DOGE ahead of Friday’s crypto sum read more
10 Analysts Assess Northern Trust: What You Need To Know
Latest Ratings for NTRS Date Firm Action From To Feb 2022 Deutsche Bank Maintains Buy Jan 2022 Morgan Stanley Maintains Equal-Weight Jan 2022 Keefe, Bruyette & Woods Upgrades Market Perform Outperform View More Analyst Ratings for NTRS View the Latest Analyst Ratings read more
Forecasting The Future: 15 Analyst Projections For Hims & Hers Health
Latest Ratings for HIMS Date Firm Action From To Mar 2022 Deutsche Bank Initiates Coverage On Hold Dec 2021 Citigroup Maintains Buy Dec 2021 Jefferies Initiates Coverage On Hold View More Analyst Ratings for HIMS View the Latest Analyst Ratings read more
10 Analysts Have This To Say About Health Catalyst
Latest Ratings for HCAT Date Firm Action From To Mar 2022 Piper Sandler Maintains Overweight Mar 2022 Raymond James Maintains Strong Buy Mar 2022 Canaccord Genuity Maintains Buy View More Analyst Ratings for HCAT View the Latest Analyst Ratings read more